T-cell receptor specific for tetanus toxoid peptides

The T-cell receptor (TCR) on CD4+ T helper cells specific for tetanus toxoid (TT) peptides is a fundamental mediator of the adaptive immune response to Clostridium tetani (PubMed: 2463368). These receptors recognize specific epitopes, such as the universal p2 (830–844) and p30 (947–967) peptides, when presented by MHC class II molecules, primarily HLA-DR (PubMed: 2585011). Because of widespread childhood vaccination, most individuals possess a robust pool of memory CD4+ T cells expressing these TCRs, which can be rapidly reactivated upon re-exposure (PubMed: 15661914). This immunological memory is strategically exploited in the design of conjugate vaccines, where TT serves as a carrier protein to provide necessary T-cell help for B-cell antibody responses against polysaccharide antigens from pathogens like Haemophilus influenzae (PubMed: 1947961). Upon engagement with the TT peptide-MHC complex, the TCR initiates signaling cascades that lead to cytokine secretion, such as IL-2 and IFN-gamma, and the expression of CD40 ligand to facilitate B-cell maturation. In clinical research, these TCRs are used as models to study T-cell repertoire diversity and the longevity of immune memory using MHC-peptide tetramers (PubMed: 10925286). While the TCR itself is not a direct drug target in the traditional sense, it is the functional target of all tetanus-containing vaccines and conjugate therapies. Safety concerns associated with activating these TCRs via vaccination include localized Arthus-type reactions and, rarely, systemic hypersensitivity (PubMed: 10668890).

Other names

Tetanus toxoid-specific T-cell receptorTT-specific TCRCD4+ T-cell receptor for tetanus toxoid

The T-cell receptor recognizes tetanus toxoid-derived peptides presented by MHC class II molecules on antigen-presenting cells, triggering T-cell activation and the provision of help to B-cells for high-affinity antibody production.